Co-fhaclan:

Oclacitinib ?, > 98%; PF-03394197 (oclacitinib); Oclacitinib PF-03394197; JAKi; trans-N-Methyl-4- (methyl-7H-pyrrolo [2,3-d] pyrimidin-4-ylamino)-cyclohexanemethanesulfon ;CyclohexaneMethanesulfonaMide, N-Methyl-4-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-, trans-;N-methyl-1-((1r,4r)-4-(methyl (7H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)cyclohexyl) methanulfonamide;N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d)pyrimidin-4) -yl) amino) cyclohexyl) methanesulfonamide

SMILES Canonical:CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3

Dùmhlachd:1.316 ± 0.06g / cm3 (Ro-shealladh)

PKA:11.59 ± 0.40 (Air a ro-innse)